This service provides evaluation of products in animal efficacy models. A product must demonstrate a potent and selective activity profile in vitro against the virus strain used in the model prior to its acceptance as a candidate for this service. Studies to determine optimal routes and schedules of drug administration can be performed.
The current contractor for this service is the University of California, San Francisco.
NIAID point of contact for this service is Brigitte Sanders, 301-496-6714.
back to top
Last Updated July 08, 2009